Oxford Biomedica to grow gene therapy business - Investors' Chronicle
Oxford BioMedica Stock Forecast: down to 190.662 GBX? - OXB Stock Price Prediction, Long-Term & Short-Term Share Revenue Prognosis with Smart Technical Analysis
Oxford Biomedica celebrates its promotion with share placing
Oxford Biomedica (LSE:OXB) Price Target Decreased by 8.43% to 941.46
Expert View: Imperial Brands, Darktrace, Tesco, Close Brothers, Oxford Biomedica
Prime Minister Boris Johnson speaks with Dipesh Sonar (centre) and Nisha Gill in the quality control laboratory, where batches of vaccine are tested, during a tour of the manufacturing facility for the
SLS acquires 3.9% shares in Oxford Biomedica for £50 million -
Liberum cuts target price for Oxford Biomedica, saying it still lacks sufficient scale - Sharecast.com
Oxford Biomedica strikes new AAV agreements with US firms - Sharecast.com
Oxford Biomedica signs new deal to make AstraZeneca COVID shot | Fox Business
Oxford Biomedica earns U.K. nod for 4th manufacturing suite to boost COVID-19 production | Fierce Pharma